Svenska
Glossary
Search
NeuroNova in Brief
Business Development
Management
Board of Directors
Neurodegenerative Diseases
Intellectual Property
Career
History
Business Development
Update pending.
© NeuroNova AB, Sweden, Tel: +46 (0)8 786 0900, Email: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Sitemap
Site policy
 
Project Pipeline
Project
Indication
Pre-clin.
IND
Phase I/II
Phase II
Phase III
sNN0029
ALS
sNN0031
Parkinson's disease
More about our Projects